Header Logo

Connection

Richard Arenas to Cell Line, Tumor

This is a "connection" page, showing publications Richard Arenas has written about Cell Line, Tumor.
Connection Strength

0.140
  1. Wong KE, Mora MC, Sultana N, Moriarty KP, Arenas RB, Yadava N, Schneider SS, Tirabassi MV. Evaluation of Rhodiola crenulata on growth and metabolism of NB-1691, an MYCN-amplified neuroblastoma cell line. Tumour Biol. 2018 Jun; 40(6):1010428318779515.
    View in: PubMed
    Score: 0.035
  2. Wong KE, Mora MC, Skinner M, McRae Page S, Crisi GM, Arenas RB, Schneider SS, Emrick T. Evaluation of PolyMPC-Dox Prodrugs in a Human Ovarian Tumor Model. Mol Pharm. 2016 05 02; 13(5):1679-87.
    View in: PubMed
    Score: 0.030
  3. Dudek MC, Wong KE, Bassa LM, Mora MC, Ser-Dolansky J, Henneberry JM, Crisi GM, Arenas RB, Schneider SS. Antineoplastic effects of Rhodiola crenulata treatment on B16-F10 melanoma. Tumour Biol. 2015 Dec; 36(12):9795-805.
    View in: PubMed
    Score: 0.028
  4. Mora MC, Bassa LM, Wong KE, Tirabassi MV, Arenas RB, Schneider SS. Rhodiola crenulata inhibits Wnt/?-catenin signaling in glioblastoma. J Surg Res. 2015 Aug; 197(2):247-55.
    View in: PubMed
    Score: 0.028
  5. Yan W, Cao QJ, Arenas RB, Bentley B, Shao R. GATA3 inhibits breast cancer metastasis through the reversal of epithelial-mesenchymal transition. J Biol Chem. 2010 Apr 30; 285(18):14042-51.
    View in: PubMed
    Score: 0.019
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.